SPECTRUM PHARMACEUTICALS INC (SPPI)
US84763A1088 - Common Stock
| MRQ (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 52.37M | 40.37M | 88.54M | 46.00M | 64.40M | |||
| Marketable Securities | 3.76M | 34.73M | 12.11M | 134.00M | 159.50M | |||
| Receivables | 33.64M | 13.61M | 1.03M | 2.50M | 10.00M | |||
| Inventories | 12.86M | 9.23M | N/A | N/A | N/A | |||
| Other Current Assets | 2.74M | 3.07M | 2.28M | 4.20M | 10.10M | |||
| Total Current Assets | 105.38M | 101.01M | 103.95M | 186.60M | 244.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.05M | 2.17M | 2.96M | 5.80M | 15.40M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Goodwill | N/A | N/A | N/A | N/A | N/A | |||
| Intangibles | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 245.00K | 157.00K | 4.64M | 4.30M | 3.70M | |||
| Total Non-Current Assets | 2.30M | 2.33M | 7.60M | 10.20M | 19.40M | |||
| TOTAL ASSETS | 107.67M | 103.34M | 111.55M | 196.80M | 263.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 7.99M | 9.06M | 19.82M | 13.50M | 13.50M | |||
| Accounts Payable | 30.89M | 33.63M | 33.41M | 34.40M | 32.00M | |||
| Other Current Liabilities | N/A | N/A | N/A | 5.30M | 16.50M | |||
| Total Current Liabilities | 38.88M | 42.69M | 53.23M | 53.10M | 62.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 28.84M | 28.67M | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Non-Current Liabilities | 13.15M | 4.10M | 10.77M | 9.40M | 11.10M | |||
| Total Non-Current Liabilities | 41.99M | 32.77M | 10.77M | 9.50M | 11.00M | |||
| TOTAL LIABILITIES | 80.87M | 75.45M | 63.99M | 62.60M | 73.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.12B | -1.12B | -1.04B | -885.30M | -724.40M | |||
| Additional Paid In Capital | 1.15B | 1.15B | 1.09B | 1.02B | 918.20M | |||
| Common Shares | 205.00K | 203.00K | 165.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | -2.89M | -2.92M | -3.04M | -1.80M | -3.50M | |||
| Shares Outstanding | 205.28M | 202.83M | 164.50M | 146.10M | 113.30M | |||
| Tangible Book Value per Share | 0.13 | 0.14 | 0.29 | 0.92 | 1.68 | |||
| Total Shareholders' Equity | 26.80M | 27.89M | 47.55M | 134.20M | 190.40M | |||
| TOTAL LIABILITIES AND EQUITY | 107.67M | 103.34M | 111.55M | 196.80M | 263.40M | |||
| Statistics | ||||||||
| Debt/Equity | 1.08 | 1.03 | N/A | N/A | N/A | |||
| Current Ratio | 2.71 | 2.37 | 1.95 | 3.51 | 3.94 | |||
| Return On Assets (ROA) | -60.34% | -72.97% | -142.21% | -81.76% | -42.79% | |||
| Return On Equity (ROE) | -242.37% | -270.37% | -333.58% | -119.90% | -59.19% | |||
All data in USD